Medicine and Dentistry
Cystic Fibrosis
100%
Patient
52%
Lung
48%
Sputum
37%
Infection
29%
Pseudomonas aeruginosa
25%
Therapeutic Procedure
22%
Bronchiectasis
21%
Pathogen
21%
Antiinfective Agent
21%
Adult
19%
Analysis
16%
Microbiome
15%
Bacterium
15%
Anti-biotics
15%
Culture
13%
In Vitro
12%
Lung Clearance
10%
Ivacaftor
10%
Chronic Obstructive Pulmonary Disease
10%
Development
10%
Patient with Cystic Fibrosis
9%
Diseases
9%
Clinical Trial
8%
Antibiotic Therapy
8%
Antibiogram
8%
Respiratory Tract Infection
8%
Tissues
7%
Silo-Filler's Disease
7%
Child
7%
Breathing
7%
Burkholderia Cepacia Complex
7%
Tobramycin
7%
Chemotherapy
7%
Methicillin Resistant Staphylococcus Aureus
6%
Inpatient
6%
Species
6%
Lung Infection
6%
Mortality
5%
Assessment
5%
Inflammation
5%
Protein
5%
Survival
5%
Chest
5%
Host
5%
Combination Therapy
5%
Azithromycin
5%
RNA 16S
5%
Transplantation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
80%
Antiinfective Agent
70%
Pseudomonas aeruginosa
43%
Infection
33%
Infectious Agent
30%
Antibiotic Agent
26%
Tobramycin
25%
Antibiotics
22%
Bacterium
20%
Chemotherapy
17%
Microflora
15%
Prevotella
11%
Methicillin-Resistant Staphylococcus Aureus
11%
Ceftazidime
10%
Lung Infection
8%
Staphylococcus
8%
Methylthioninium Chloride
8%
Antibiotic Resistance
8%
Bronchiectasis
8%
Chronic Obstructive Lung Disease
8%
Photosensitizer
8%
Extended Spectrum Beta Lactamase
7%
Burkholderia Cepacia Complex
7%
Tetrazolium
7%
Microbiome
7%
Respiratory Tract
7%
Cystic Fibrosis
7%
Murepavadin
7%
Fosfomycin
7%
Gentamicin
6%
Carbon Tetrachloride
6%
Biomaterial
6%
Drug
6%
Antibiotic Therapy
5%
Penicillinase
5%
Minimum Inhibitory Concentration
5%
Antimicrobial Resistance
5%
Implant
5%
Virulence
5%
Inhalation
5%
Anaerobic Bacterium
5%
Polymer
5%
Immunology and Microbiology
Lung
57%
Sputum
36%
Sample
35%
Pseudomonas aeruginosa
33%
Microflora
30%
Biofilm
20%
Infectious Agent
18%
Bacterium
17%
Taxon
17%
Species
15%
Microbiome
15%
Antibiotic Sensitivity
14%
Anaerobic Bacterium
14%
Gene
13%
Inflammation
13%
Antimicrobial Resistance
12%
Minimum Inhibitory Concentration
11%
Prevotella
11%
Pseudomonas
10%
Time
9%
Microflora
9%
Genus
8%
Streptococcus
8%
Mutation
8%
Health
7%
Anaerobe
6%
Reduction (Chemistry)
6%
Association
6%
Blood Plasma
6%
Tissues
6%
Mortality
6%
Density
6%
Urine
5%
Growth
5%
Position
5%
Airway
5%
Veillonella
5%
Virulence
5%
Lung Clearance
5%
Modulation
5%
Total Viable Count
5%
Methicillin-Resistant Staphylococcus Aureus
5%